Angiodynamics (ANGO) Cash & Current Investments (2010 - 2026)

Angiodynamics has reported Cash & Current Investments for 17 years, with the latest figure at $37.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 15.53% year-over-year to $37.8 million; the trailing twelve-month figure through Feb 2026 stood at $37.8 million (down 15.53% YoY), and the FY2025 full-year result was $55.9 million, down 26.51% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $37.8 million, down from $41.6 million in the prior quarter.
• The five-year high for Cash & Current Investments was $78.5 million in Q1 2024, with the low at $23.9 million in Q1 2022.
• Historically, Cash & Current Investments has averaged $46.0 million across 5 years, with a median of $44.6 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 56.14% — and 2024, when it soared 160.54%.
• Angiodynamics' Cash & Current Investments stood at $29.9 million in 2022, then soared by 103.96% to $60.9 million in 2023, then fell by 11.18% to $54.1 million in 2024, then decreased by 23.02% to $41.6 million in 2025, then dropped by 9.19% to $37.8 million in 2026.
• The last three Cash & Current Investments figures came in at $37.8 million (Q1 2026), $41.6 million (Q4 2025), and $38.8 million (Q3 2025), per Business Quant data.